The bill rescinds normal trade relations (NTR) treatment for products of the People’s Republic of China effective on enactment and requires that any future extension of nondiscriminatory treatment follow the procedures in chapter 1 of title IV of the Trade Act of 1974 as they applied at the time China joined the WTO. It also preserves an existing executive waiver for a short transition period and amends section 402 of the Trade Act to add a list of human-rights, labor, and national-security-related grounds that make Chinese-origin products ineligible for NTR.
This is consequential because it converts trade classification into an enforcement lever tied explicitly to a broad set of non-trade benchmarks — from organ harvesting and forced sterilization to economic espionage and the operation of detention camps — and it creates a time-limited presidential waiver process with semiannual reporting and a defined Congressional disapproval route. Compliance officers, importers, export-dependent firms, and agencies that issue credits or guarantees will need to map exposures and prepare for rapid changes in tariff treatment and program eligibility if triggers are invoked or the waiver is allowed to lapse.
At a Glance
What It Does
The bill withdraws NTR for Chinese products on enactment and limits any future restoration to the procedures in chapter 1 of title IV of the Trade Act of 1974. It adds a new subsection to section 402 listing nine specific bases (human-rights abuses, labor standards, economic espionage, etc.) that can render Chinese products ineligible, and it establishes reporting, waiver, and Congressional review mechanics.
Who It Affects
U.S. importers and retailers of Chinese-origin goods, multinational companies with China-based supply chains, agencies that extend credits or guarantees (for example, Ex-Im and U.S. development finance entities), and any office negotiating or entering commercial agreements with China.
Why It Matters
The measure ties trade status to non-trade objectives, creating a statutory path for rapidly changing tariff and program eligibility and adding compliance and geopolitical risk to cross-border supply chains. It centralizes the decision with the President while giving Congress a fast-track oversight mechanism for any executive waiver extensions.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
On day one the bill strips the People’s Republic of China of nondiscriminatory (normal) trade relations with the United States. That means the legal foundation that treated Chinese products as eligible for MFN-style tariff treatment is removed; moving forward, the bill says products of China can receive such treatment only if the strict procedures in chapter 1 of title IV of the Trade Act of 1974 — as they existed immediately before China’s WTO accession — are applied.
The statute also provides a short, automatic continuity: waiver authority that had been in force the day before China’s WTO entry is treated as still in effect for 90 days after enactment to ease the transition.
The bill expands section 402 of the Trade Act by adding a new subsection that specifies a set of conditions that will render Chinese products ineligible for NTR. These grounds include failure to meet certain emigration and human-rights benchmarks, noncompliance with ILO standards, operation of detention or ‘vocational training’ centers, harassment of Chinese nationals abroad, suppression of Tibetan cultural and religious rights, systematic economic espionage, organ harvesting, forced abortion or sterilization practices, and the like.
If the President determines China is violating any listed clause, the bill bars NTR treatment and also prevents China from participating in U.S. credit or investment guarantee programs and blocks the conclusion of U.S. commercial agreements while the determination stands.The statute requires the President to send Congress a substantive report before NTR can be restored: twice-yearly submissions (June 30 and December 31) must describe Chinese laws and policies relevant to the listed items. The President may, however, issue a 12‑month waiver by Executive order if he certifies in a report that the waiver would substantially promote the statute’s objectives and that China has given assurances it will change practices.
That waiver can be extended in successive 12‑month periods on the President’s recommendation, but each extension is subject to a prescribed Congressional disapproval process (a joint resolution with fast-track procedures and a defined timeline for consideration and veto-override action).Operationally, the bill gives the executive branch authority to make the binary determination that triggers ineligibility and to use a time-limited waiver to manage diplomatic and economic effects. At the same time, Congress receives a recurring information flow and an expedited path to terminate executive waivers.
For businesses and agencies, the immediate issues are (1) whether particular goods qualify as “products of the People’s Republic of China” for tariff and program purposes, (2) how non-trade benchmarks will be documented and adjudicated inside the executive branch, and (3) how to prepare for possible rapid changes to tariff classification, access to credit programs, and the legal risk of sanctions or retaliatory measures by trading partners.
The Five Things You Need to Know
On enactment the bill withdraws normal trade relations (NTR) treatment for products of the People’s Republic of China and makes that withdrawal statutory.
Any future restoration of NTR for Chinese products must follow chapter 1 of title IV of the Trade Act of 1974 as it stood the day before China’s WTO accession — a procedural constraint that tightens the path to reinstatement.
The bill adds nine discrete ineligibility grounds (section 402(f)), including operation of detention centers, forced organ harvesting, forced sterilization or abortion, systematic economic espionage, and harassment of Chinese nationals abroad.
The President must submit reports to Congress describing Chinese laws and policies on the listed matters on or before June 30 and December 31 each year while NTR is in effect; the President may issue a 12‑month waiver but extensions require a presidential recommendation and are subject to an expedited Congressional disapproval procedure.
While a determination of ineligibility is in effect the bill bars the PRC from participating in U.S. credit, credit‑guarantee, or investment‑guarantee programs and prevents the U.S. from concluding commercial agreements with China.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Identifies the Act as the 'China Trade Relations Act of 2025.' This is purely formal but signals the legislative intent to treat trade relations with China as the bill’s central subject.
Immediate withdrawal of normal trade relations and transitional waiver
Subsections (1)–(3) make NTR inapplicable to Chinese products effective on enactment and require any restoration to follow chapter 1 of title IV of the Trade Act of 1974 as it existed on the day before China’s WTO accession. Practically, the provision revokes the statutory basis for routine nondiscriminatory tariff treatment and authorizes different treatment pending the chapter 1 procedures. It also deems any waiver authority that had been in effect under prior law as not expired and continues it for 90 days after enactment, providing an immediate but brief bridge so agencies and the private sector can begin adjusting.
Scope of ineligibility and prohibited program participation
Adds a broad clause stating that products of China shall not be eligible for nondiscriminatory treatment and that the PRC shall be excluded from U.S. programs granting credits, credit guarantees, or investment guarantees and from entering commercial agreements while the condition applies. The provision is deliberately wide: it links tariff classification to programmatic and diplomatic exclusion, not just customs treatment, expanding the practical consequences beyond duties to financing and formal commercial pacts.
Biannual reporting condition for restoration
Requires the President to submit a report on or before June 30 and December 31 each year so long as Chinese products receive NTR or China participates in U.S. credit or guarantee programs or commercial agreements. The report must explain the nature and implementation of Chinese laws and policies relevant to the listed violations. The semiannual cadence institutionalizes congressional oversight and creates a recurring documentary record that agencies, courts, and private parties can use to assess the status of obligations and any change in U.S. treatment.
Presidential waiver, extension procedures, and Congressional disapproval
Authorizes the President to waive the application of the ineligibility rules for 12 months if the President certifies the waiver will substantially promote statutory objectives and provides assurances from China. The President may recommend successive 12‑month extensions, but each extension triggers a Congress-facing process: recommendations must be transmitted at least 30 days before expiration, and Congress can disapprove via a joint resolution using expedited procedures. If Congress enacts a disapproving joint resolution, the waiver authority ceases after a 60‑day period. These mechanics create a predictable but politically charged path for balancing diplomacy and enforcement.
Clerical amendment to the Trade Act table of contents
Updates the Trade Act of 1974 table of contents to reflect the amended section heading — replacing the former 'Freedom of Emigration in East‑West Trade' with 'East‑West Trade and Human Rights.' The change formalizes that Congress intends the section to address broader human-rights and non‑trade concerns in trade policy.
This bill is one of many.
Codify tracks hundreds of bills on Trade across all five countries.
Explore Trade in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- U.S. domestic manufacturers competing with Chinese imports — reduced eligibility for nondiscriminatory treatment can raise duties or justify discriminatory measures that improve competitive positioning for domestic producers.
- Human‑rights and labor advocacy organizations — the statute converts several human‑rights concerns into statutory triggers, giving these groups a durable lever to press for changes and to make the executive accountable through required reports.
- Congressional oversight offices and committees — the biannual reporting requirement and the expedited disapproval path increase legislative visibility and formal control over any executive decision to waive the law’s ineligibility provisions.
Who Bears the Cost
- U.S. importers, wholesalers, and retailers that source finished goods or components from China — they face sudden tariff exposure, disrupted supply chains, increased compliance costs to establish country‑of‑origin, and potential need to re‑engineer sourcing.
- Multinational companies and contract manufacturers that rely on integrated China supply chains — complex rules of origin disputes and rapid shifts in trade status can force costly operational changes, inventory reallocation, and contractual renegotiations.
- Federal agencies that administer credit or guarantee programs (for example, the Export‑Import Bank and U.S. International Development Finance Corporation) — they must implement statutory exclusions, increase monitoring, and produce the presidential and supporting reports, creating administrative burdens and potential legal exposure.
- U.S. consumers and downstream businesses — if duties or market access restrictions follow, prices on affected goods are likely to rise and supply reliability may decline, passing costs through the economy.
Key Issues
The Core Tension
The central dilemma is whether to use trade law as a blunt instrument to coerce behavioral change on human rights and national‑security grounds — a tool that can produce real leverage but also causes immediate economic pain and legal exposure — or to preserve stable, rule‑based trade that minimizes disruption but leaves fewer levers to address the non‑trade harms Congress lists.
The bill embeds a classic leverage strategy — convert trade preferences into conditional instruments tied to human‑rights and security benchmarks — but the mechanics create several real implementation headaches. The President is the exclusive factfinder for determining violations and for issuing waivers, yet the statute provides little in the way of evidentiary standards or interagency procedure for how determinations on organ harvesting, 'vocational training centers,' or economic espionage are to be documented, contested, or resolved.
That gap invites disputes over agency processes, possible litigation by affected businesses or third parties, and interagency jockeying over facts and messaging.
Another set of trade‑policy frictions arises from the breadth of what becomes ineligible and the consequential cross‑program prohibitions. Tying exclusion from NTR to ineligibility for U.S. credit and investment guarantees multiplies the statute’s reach across agencies that have different mandates and statutory frameworks; those agencies will need to translate the single presidential determination into concrete program rules and contractual consequences.
Finally, the waiver architecture creates political ambiguity: the President can blunt adverse consequences by issuing waivers, but repeated waivers will undercut the statute’s aim of using trade pressure to change behavior. At the same time, allowing waivers makes the law more administrable as a diplomatic tool, so the statute deliberately builds in the very uncertainty it purports to remove.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.